Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1983 2
1984 3
1985 7
1986 1
1987 7
1988 9
1989 5
1990 2
1991 3
1992 5
1993 5
1994 3
1995 5
1997 4
1998 2
1999 3
2000 3
2001 6
2002 4
2003 3
2004 7
2005 7
2006 6
2007 8
2008 6
2009 12
2010 17
2011 7
2012 8
2013 12
2014 11
2015 16
2016 11
2017 10
2018 13
2019 7
2020 12
2021 8
2022 9
2023 5
2024 5
2025 5
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

256 results

Results by year

Filters applied: . Clear all
Page 1
Perkutan koronar intervensjon – hvor og når?
Nordrehaug JE. Nordrehaug JE. Tidsskr Nor Laegeforen. 2024 May 27;144(8). doi: 10.4045/tidsskr.24.0274. Print 2024 Jun 25. Tidsskr Nor Laegeforen. 2024. PMID: 38934320 Free article. Norwegian. No abstract available.
Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study.
Erlinge D, Maehara A, Ben-Yehuda O, Bøtker HE, Maeng M, Kjøller-Hansen L, Engstrøm T, Matsumura M, Crowley A, Dressler O, Mintz GS, Fröbert O, Persson J, Wiseth R, Larsen AI, Okkels Jensen L, Nordrehaug JE, Bleie Ø, Omerovic E, Held C, James SK, Ali ZA, Muller JE, Stone GW; PROSPECT II Investigators. Erlinge D, et al. Among authors: nordrehaug je. Lancet. 2021 Mar 13;397(10278):985-995. doi: 10.1016/S0140-6736(21)00249-X. Lancet. 2021. PMID: 33714389
Long-term use of ticagrelor in patients with prior myocardial infarction.
Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Oude Ophuis T, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS; PEGASUS-TIMI 54 Steering Committee and Investigators. Bonaca MP, et al. N Engl J Med. 2015 May 7;372(19):1791-800. doi: 10.1056/NEJMoa1500857. Epub 2015 Mar 14. N Engl J Med. 2015. PMID: 25773268 Free article. Clinical Trial.
Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques: A PROSPECT II Substudy.
Erlinge D, Tsimikas S, Maeng M, Maehara A, Larsen AI, Engstrøm T, Kjøller-Hansen L, Matsumura M, Ben-Yehuda O, Bøtker HE, Fröbert O, Persson J, Wiseth R, Jensen LO, Nordrehaug JE, Trovik T, Jensen U, Bleie Ø, Omerovic E, James SK, Rylance R, Sharma T, Ali ZA, Stone GW. Erlinge D, et al. Among authors: nordrehaug je. J Am Coll Cardiol. 2025 Jun 3;85(21):2011-2024. doi: 10.1016/j.jacc.2025.04.013. J Am Coll Cardiol. 2025. PMID: 40436465
Inflammatory markers after supplementation with marine n-3 or plant n-6 PUFAs: A randomized double-blind crossover study.
Grytten E, Laupsa-Borge J, Cetin K, Bohov P, Nordrehaug JE, Skorve J, Berge RK, Strand E, Bjørndal B, Nygård OK, Rostrup E, Mellgren G, Dankel SN. Grytten E, et al. Among authors: nordrehaug je. J Lipid Res. 2025 Apr;66(4):100770. doi: 10.1016/j.jlr.2025.100770. Epub 2025 Mar 8. J Lipid Res. 2025. PMID: 40058591 Free PMC article. Clinical Trial.
Relationships of hsCRP to High-Risk Vulnerable Plaque After NSTEMI: Insights From the PROSPECT II Trial.
Fröbert O, Stone GW, Larsen AI, Zhou Z, Kotinkaduwa LN, Engstrøm T, Kjøller-Hansen L, Maeng M, Matsumura M, Ben-Yehuda O, Bøtker HE, Persson J, Wiseth R, Jensen LO, Nordrehaug JE, Trovik T, Jensen U, Bleie Ø, James SK, Ali ZA, Omerovic E, Erlinge D, Maehara A. Fröbert O, et al. Among authors: nordrehaug je. JACC Cardiovasc Interv. 2025 May 26;18(10):1217-1228. doi: 10.1016/j.jcin.2025.01.440. Epub 2025 Apr 23. JACC Cardiovasc Interv. 2025. PMID: 40272345 Clinical Trial.
Effects of extended-release niacin with laropiprant in high-risk patients.
HPS2-THRIVE Collaborative Group; Landray MJ, Haynes R, Hopewell JC, Parish S, Aung T, Tomson J, Wallendszus K, Craig M, Jiang L, Collins R, Armitage J. HPS2-THRIVE Collaborative Group, et al. N Engl J Med. 2014 Jul 17;371(3):203-12. doi: 10.1056/NEJMoa1300955. N Engl J Med. 2014. PMID: 25014686 Free article. Clinical Trial.
Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy.
Thrane PG, Maeng M, Maehara A, Bøtker HE, Mintz GS, Kjøller-Hansen L, Engstrøm T, Matsumura M, Kotinkaduwa LN, Fröbert O, Persson J, Wiseth R, Larsen AI, Jensen LO, Nordrehaug JE, Bleie Ø, Held C, James SK, Ali ZA, Erlinge D, Stone GW. Thrane PG, et al. Among authors: nordrehaug je. Circulation. 2025 Jun 24;151(25):1767-1779. doi: 10.1161/CIRCULATIONAHA.124.071980. Epub 2025 Jun 23. Circulation. 2025. PMID: 40549845 Free article.
Hyperkalaemia as a differential diagnosis in chest pain.
Nordrehaug JE. Nordrehaug JE. Tidsskr Nor Laegeforen. 2022 Mar 22;142(5). doi: 10.4045/tidsskr.22.0154. Print 2022 Mar 22. Tidsskr Nor Laegeforen. 2022. PMID: 35324117 Free article. English, Norwegian. No abstract available.
Association Between Physiological Significance and Vulnerable Plaque Characteristics in Patients With Myocardial Infarction: A Prospect II Substudy.
Arslani K, Engstrøm T, Maeng M, Kjøller-Hansen L, Maehara A, Zhou Z, Ben-Yehuda O, Bøtker HE, Matsumura M, Mintz GS, Fröbert O, Persson J, Wiseth R, Larsen AI, Jensen LO, Nordrehaug JE, Bleie Ø, Omerovic E, Held C, James SK, Ali ZA, Erlinge D, Stone GW. Arslani K, et al. Among authors: nordrehaug je. JACC Cardiovasc Imaging. 2025 Jun;18(6):696-706. doi: 10.1016/j.jcmg.2024.11.002. Epub 2025 Feb 24. JACC Cardiovasc Imaging. 2025. PMID: 39998456
256 results